Specific Intracellular Uptake of Herceptin-conjugated CdSe/ZnS Quantum Dots into Breast Cancer Cells
Herceptin, a typical monoclonal antibody, was immobilized on the surface of CdSe/ZnS core-shell quantum dots (QDs) to enhance their specific interactions with breast cancer cells (SK-BR3). the mean size of the core-shell quantum dots (28 nm), as determined by dynamic light scattering, increased to 86 nm after herceptin immobilization. the in vitro cell culture experiment showed that the keratin forming cancer cells (KB) proliferated well in the presence of herceptin-conjugated QDs (QD-Her, 5 nmol/mL), whereas most of the breast cancer cells (SK-BR3) had died. to clarify the mechanism of cell death, the interaction of SK-BR3 cells with QD-Her was examined by confocal laser scanning microscopy. as a result, the QD-Her bound specifically to the membrane of SK-BR3, which became almost saturated after 6 hours incubation. This suggests that the growth signal of breast cancer cells is inhibited completely by the specific binding of herceptin to the Her-2 receptor of SK-BR3 membrane, resulting in cell death.
S. Han et al., "Specific Intracellular Uptake of Herceptin-conjugated CdSe/ZnS Quantum Dots into Breast Cancer Cells," BioMed Research International, vol. 2014, Hindawi Publishing Corporation, Jan 2014.
The definitive version is available at http://dx.doi.org/10.1155/2014/954307
International Standard Serial Number (ISSN)
Article - Journal
© 2014 Hindawi Publishing Corporation, All rights reserved.